The EZ-IO provides access through the bone marrow cavity to quickly infuse blood, medications and fluids into critically ill patients who might die waiting for traditional IV lines.
The EZ-IO provides access through the bone marrow cavity to quickly infuse blood, medications and fluids into critically ill patients who might die waiting for traditional IV lines.

The EZ-IO, developed by Vidacare Corporation of San Antonio with research assistance from faculty members at the Health Science Center, won the medical devices category in the Wall Street Journal’s eighth annual Technology Innovation Awards.

Share this article